STAAR Surgical Company
STAA · NASDAQ
11/5/2025 | 9/26/2025 | 6/27/2025 | 3/28/2025 | |
|---|---|---|---|---|
| Market Cap | $1,250 | – | $838 | $878 |
| - Cash | $176 | – | $167 | $173 |
| + Debt | $39 | – | $41 | $37 |
| Enterprise Value | $1,113 | – | $711 | $741 |
| Revenue | – | $95 | $44 | $43 |
| % Growth | – | 113.7% | 4.1% | – |
| Gross Profit | – | $78 | $33 | $28 |
| % Margin | – | 82.2% | 74% | 65.8% |
| EBITDA | – | $26 | -$23 | -$32 |
| % Margin | – | 27.9% | -51.3% | -76.1% |
| Net Income | – | $9 | -$17 | -$54 |
| % Margin | – | 9.4% | -37.9% | -127.3% |
| EPS Diluted | – | 0.18 | -0.34 | -1.1 |
| % Growth | – | 152.9% | 69.1% | – |
| Operating Cash Flow | $3 | – | -$27 | -$6 |
| Capital Expenditures | -$1 | – | -$2 | -$1 |
| Free Cash Flow | $2 | – | -$29 | -$7 |